In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies

by Elena Iemma | Apr 1, 2024

Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics

by Elena Iemma | Sep 12, 2023

Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning

by Elena Iemma | Sep 6, 2023

Identification of immunodominant T cell epitopes induced by natural Zika virus infection

by Elena Iemma | Aug 30, 2023

Poster: Multi-Factored Immunogenicity Risk Assessment Approach for Bispecific Immune-Cell Engagers

by Elena Iemma | May 1, 2023

Multi-Factored Immunogenicity Risk Assessment Approach for Bispecific Immune Cell-Engagers